Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Optimization in T-lymphoblastic Lymphoma (GMALL T-LBL 1/2004)
NCT00199017Phase 4Completed
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Apr 2004
- Primary completion
- Mar 2009
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, prednisolone, cyclophosphamide, vincristine, daunorubicin in T-cell lymphoblastic lymphoma (T-LBL), sponsored by Universitätsklinikum Frankfurt. Started Apr 2004; status: completed.
02
Drugs
dexamethasoneprednisolonecyclophosphamidevincristinedaunorubicin
03
Conditions
T-cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT00199017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199017.